These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 36380228)
21. Expression of insulin-like growth factor-II mRNA in fetal kidney and Wilms' tumor. An in situ hybridization study. Paik S; Rosen N; Jung W; You JM; Lippman ME; Perdue JF; Yee D Lab Invest; 1989 Nov; 61(5):522-6. PubMed ID: 2554059 [TBL] [Abstract][Full Text] [Related]
22. Association of E2F3 expression with clinicopathological features of Wilms' tumors. An Q; Wang Y; An R; Li Y; Yao T; Zhai B; Sun X J Pediatr Surg; 2013 Nov; 48(11):2187-93. PubMed ID: 24210184 [TBL] [Abstract][Full Text] [Related]
28. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity. Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497 [TBL] [Abstract][Full Text] [Related]
29. Blastemal cells of nephroblastomatosis complex share an onco-developmental antigen with embryonic kidney and Wilms' tumor. An immunohistochemical study on polysialic acid distribution. Roth J; Blaha I; Bitter-Suermann D; Heitz PU Am J Pathol; 1988 Dec; 133(3):596-608. PubMed ID: 2849302 [TBL] [Abstract][Full Text] [Related]
30. Expression of class I and II major histocompatibility complex antigens in Wilms' tumour and normal developing human kidney. Borthwick GM; Hughes L; Holmes CH; Davis SJ; Stirrat GM Br J Cancer; 1988 Dec; 58(6):753-61. PubMed ID: 2465017 [TBL] [Abstract][Full Text] [Related]
31. Identification of genetically aberrant cell lineages in Wilms' tumors. Weremowicz S; Kozakewich HP; Haber D; Park S; Morton CC; Fletcher JA Genes Chromosomes Cancer; 1994 May; 10(1):40-8. PubMed ID: 7519872 [TBL] [Abstract][Full Text] [Related]
32. Wilms' tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells. Menke AL; Riteco N; van Ham RC; de Bruyne C; Rauscher FJ; van der Eb AJ; Jochemsen AG Oncogene; 1996 Feb; 12(3):537-46. PubMed ID: 8637710 [TBL] [Abstract][Full Text] [Related]
33. The role of TCF3 as potential master regulator in blastemal Wilms tumors. Kehl T; Schneider L; Kattler K; Stöckel D; Wegert J; Gerstner N; Ludwig N; Distler U; Tenzer S; Gessler M; Walter J; Keller A; Graf N; Meese E; Lenhof HP Int J Cancer; 2019 Mar; 144(6):1432-1443. PubMed ID: 30155889 [TBL] [Abstract][Full Text] [Related]
35. Expression of WT1 protein in fetal kidneys and Wilms tumors. Grubb GR; Yun K; Williams BR; Eccles MR; Reeve AE Lab Invest; 1994 Oct; 71(4):472-9. PubMed ID: 7967503 [TBL] [Abstract][Full Text] [Related]
36. Gene expression in Wilms' tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition. Li CM; Guo M; Borczuk A; Powell CA; Wei M; Thaker HM; Friedman R; Klein U; Tycko B Am J Pathol; 2002 Jun; 160(6):2181-90. PubMed ID: 12057921 [TBL] [Abstract][Full Text] [Related]
37. Glutathione S-transferase expression in fetal kidney and Wilms' tumour. Harrison DJ; Hallam L; Lauder J Br J Cancer; 1990 Jun; 61(6):836-40. PubMed ID: 2164834 [TBL] [Abstract][Full Text] [Related]
38. Alternative splicing modulates cancer aggressiveness: role in EMT/metastasis and chemoresistance. Roy Burman D; Das S; Das C; Bhattacharya R Mol Biol Rep; 2021 Jan; 48(1):897-914. PubMed ID: 33400075 [TBL] [Abstract][Full Text] [Related]
39. Expression of the PAX2 gene in human fetal kidney and Wilms' tumor. Eccles MR; Wallis LJ; Fidler AE; Spurr NK; Goodfellow PJ; Reeve AE Cell Growth Differ; 1992 May; 3(5):279-89. PubMed ID: 1378753 [TBL] [Abstract][Full Text] [Related]
40. A point mutation within exon 5 of the WT1 gene of a sporadic unilateral Wilms' tumor alters gene function. Guan LS; Liu JJ; Xu YH; Wang ZY Cancer Res; 1998 Sep; 58(18):4180-4. PubMed ID: 9751632 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]